Microvascular Therapeutics Appoints Charles Garrison, MD, to Scientific Advisory Board

emeuillet0

9 hours ago

1 min read

Experienced pathologist, biotechnology entrepreneur, and life sciences investor will advise MVT on scientific and medical development

Recent Posts

University of Utah researchers use MVT-101 phase-shift nanobubbles with focused ultrasound and MRI to confirm treatment location

https://conexiant.com/cardiology/articles/early-phase-data-support-novel-contrast-agent/